Regeneron Pharmaceuticals, Inc. (REGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$754.91
Day's range
$783.65

Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 9.08 M $7.00 B   0.30% 8.82%
BLACKROCK, INC. 02/12/2026 8.74 M $6.75 B   -1.09% 8.49%
STATE STREET CORP 02/13/2026 4.66 M $3.60 B   -0.65% 4.53%
DODGE & COX 02/13/2026 4.60 M $3.55 B   1.00% 4.47%
JPMORGAN CHASE & CO 02/11/2026 3.94 M $3.04 B   -3.25% 3.77%
FRANKLIN RESOURCES INC 02/11/2026 2.56 M $1.98 B   4.36% 2.49%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.52 M $1.94 B   -0.65% 2.45%
FMR LLC 02/17/2026 2.32 M $1.79 B   19.82% 2.22%
NUVEEN, LLC 02/12/2026 2.01 M $1.55 B   71.07% 1.95%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 1.95 M $1.50 B   142.24% 1.89%
LOOMIS SAYLES & CO L P 02/12/2026 1.93 M $1.49 B   -2.28% 1.88%
INVESCO LTD. 02/19/2026 1.59 M $1.23 B   7.18% 1.55%
CAPITAL WORLD INVESTORS 02/11/2026 1.40 M $1.08 B   -30.04% 1.36%
MORGAN STANLEY 02/13/2026 1.39 M $1.07 B   -4.25% 1.35%
NORGES BANK 02/10/2026 1.31 M $1.01 B   100.00% 1.27%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.16 M $893.38 M   0.30% 1.12%
GOLDMAN SACHS GROUP INC 03/25/2026 1.10 M $846.99 M   15.16% 1.07%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 995.71 K $768.52 M   38.03% 0.95%
NORTHERN TRUST CORP 02/17/2026 944.93 K $729.37 M   -4.05% 0.90%
AMUNDI 02/17/2026 791.91 K $611.25 M   27.37% 0.77%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 778.00 K $600.52 M   2.97% 0.74%
BANK OF NEW YORK MELLON CORP 02/10/2026 764.24 K $589.90 M   13.79% 0.74%
DEUTSCHE BANK AG\ 02/11/2026 763.93 K $589.65 M   9.65% 0.73%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 745.23 K $575.22 M   0.14% 0.72%
LEGAL & GENERAL GROUP PLC 02/09/2026 743.03 K $573.52 M   -3.55% 0.72%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 664.47 K $512.88 M   8,620.01% 0.64%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 639.60 K $493.69 M   2.47% 0.62%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 610.50 K $471.23 M   -7.26% 0.59%
TWO SIGMA ADVISERS, LP 02/17/2026 604.54 K $466.63 M   -34.73% 0.59%
AMERICAN CENTURY COMPANIES INC 02/13/2026 551.49 K $425.68 M   -16.52% 0.54%
FIL LTD 02/17/2026 529.19 K $408.47 M   182.20% 0.51%
JANE STREET GROUP, LLC 02/12/2026 516.20 K $398.44 M   15.82% 0.50%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 499.54 K $385.59 M   0.09% 0.49%
MARSHALL WACE, LLP 02/13/2026 478.55 K $369.38 M   23.69% 0.47%
ALLIANCEBERNSTEIN L.P. 02/17/2026 478.39 K $369.25 M   -8.68% 0.46%
HOLOCENE ADVISORS, LP 02/17/2026 460.72 K $355.62 M   203.64% 0.45%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 445.80 K $344.05 M   -23.73% 0.43%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 440.84 K $340.27 M   -7.71% 0.43%
NEUBERGER BERMAN GROUP LLC 02/13/2026 422.13 K $325.83 M   1.54% 0.40%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 421.23 K $325.26 M   10.55% 0.40%
CENTIVA CAPITAL, LP 02/13/2026 407.10 K $314.23 M   1.78% 0.39%
PACER ADVISORS, INC. 02/24/2026 397.67 K $306.95 M   -10.70% 0.39%
TD ASSET MANAGEMENT INC 02/10/2026 397.55 K $306.86 M   6.22% 0.39%
MILLENNIUM MANAGEMENT LLC 02/17/2026 379.77 K $293.13 M   88.86% 0.37%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 367.87 K $284.72 M   13.76% 0.36%
NATIONAL PENSION SERVICE 02/10/2026 360.99 K $278.64 M   29.79% 0.35%
ROYAL BANK OF CANADA 02/17/2026 345.22 K $266.47 M   -7.47% 0.34%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 02/17/2026 342.32 K $264.23 M   -25.99% 0.33%
HSBC HOLDINGS PLC 03/20/2026 318.81 K $246.22 M   -13.83% 0.31%
BARCLAYS PLC 02/13/2026 311.17 K $240.18 M   -4.53% 0.30%

Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 1982 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Nuveen, LLC: 2.07 M

Bank of New York Mellon Corp: 765,411

Robeco Institutional Asset Management B.V.: 348,787

Pictet Asset Management Holding SA: 337,254

HSBC HOLDINGS PLC: 323,338

UBS Group AG: 299,979

86.65% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 116.90 M shares in the last 24 months. This purchase volume represents approximately $91.37 B in transactions.